This course focuses on the systemic impact of chronic hyperglycemia and metabolic dysfunction on the body’s smallest blood vessels. Clinicians will review the underlying mechanisms driving diabetic retinopathy, nephropathy, and neuropathy, learning how subvascular damage evolves over time. The curriculum highlights practical protocols for early screening—such as monitoring eGFR, urine albumin-to-creatinine ratios (UACR), and comprehensive foot and eye examinations—while providing actionable prevention strategies to halt microvascular decline and preserve patient quality of life.